Cargando…
Definitions of non-response and response to biological therapy for severe asthma: a systematic review
BACKGROUND: Biologics have proven efficacy for patients with severe asthma but there is lack of consensus on defining response. We systematically reviewed and appraised methodologically developed, defined and evaluated definitions of non-response and response to biologics for severe asthma. METHODS:...
Autores principales: | Khaleva, Ekaterina, Rattu, Anna, Brightling, Chris, Bush, Andrew, Bourdin, Arnaud, Bossios, Apostolos, Chung, Kian Fan, Chaudhuri, Rekha, Coleman, Courtney, Djukanovic, Ratko, Dahlén, Sven-Erik, Exley, Andrew, Fleming, Louise, Fowler, Stephen J., Gupta, Atul, Hamelmann, Eckard, Koppelman, Gerard H., Melén, Erik, Mahler, Vera, Seddon, Paul, Singer, Florian, Porsbjerg, Celeste, Ramiconi, Valeria, Rusconi, Franca, Yasinska, Valentyna, Roberts, Graham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152254/ https://www.ncbi.nlm.nih.gov/pubmed/37143849 http://dx.doi.org/10.1183/23120541.00444-2022 |
Ejemplares similares
-
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)
por: Khaleva, Ekaterina, et al.
Publicado: (2023) -
Narrative review to capture patients’ perceptions and opinions about non-response and response to biological therapy for severe asthma
por: Coleman, Courtney, et al.
Publicado: (2023) -
On Genetics, Lung Developmental Biology, and Adult Lung
Function
por: Melén, Erik, et al.
Publicado: (2020) -
Real‐world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systematic review and meta‐analysis
por: Charles, David, et al.
Publicado: (2022) -
Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
por: Hamelmann, Eckard
Publicado: (2018)